IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY was filed as Figurative mark on 10/24/2018 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Quadrilaterals #Letters presenting a special form of writing #Numerals presenting a special form of writing #Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded corners #One quadrilateral #Quadrilaterals containing one or more numerals #Quadrilaterals containing one or more letters #Quadrilaterals with dark surfaces or parts of surfaces #Series of letters presenting different forms of writing #Numerals juxtaposed or joined to a letter or a figurative element

Trademark Details Last update: December 23, 2021

Trademark form Figurative mark
File reference 1440678
Countries European Community
Base trademark GB No. UK00003324486, July 13, 2018
Application date October 24, 2018
Expiration date October 24, 2028

Trademark owner

5 Fleet Place
London EC4M 7RD
GB

Trademark representatives

Seventh Floor Offices Artillery House GB

goods and services

05 Pharmaceutical preparations for the treatment of cancer; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, incorporating radioactive material for treatment of cancerous tumours; beads, radioactive glass beads; pharmaceutical preparations for use in chemotherapy
10 Surgical and medical apparatus and instruments; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, including microscopic glass beads, incorporating radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, including radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment; surgical, medical and diagnostic materials, devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and BPH; medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; parts and fittings for all of the aforesaid goods

Trademark history

Date Document number Area Entry
July 16, 2019 2019/31 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 9, 2019 2019/3 Gaz EM Rejection
October 24, 2018 2018/50 Gaz GB Registration

ID: 141440678